Buy or sell Viome stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Viome Stock
Discovering predictive biomarkers to eradicate all diseases.
About Viome Stock
Viome is a team of leading entrepreneurs, scientists, and physicians. Their proven expertise is why Viome is the only private company trusted with exclusive license to technology first developed at the prestigious Los Alamos National Laboratory. Viome’s pioneering artificial learning engines are designed to not only analyze your data, but to aggregate all the biological data they receive. As the sample size grows, their machines will spot trends and influences, which will unlock scientific breakthroughs.
Funding History
July 2017 | $15.0M |
---|
Management
Founder & President
Deepak Savadatti
Founder & CEO
Naveen Jain
Chief Medical Officer
Helen Messier
Press
Forbes - Jul, 5 2018
SFGate - Jun, 4 2018
MobiHealthNews - Aug, 7 2017
The Seattle Times - Jul, 31 2017
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase